Skip to main content
Aclarion, Inc. logo

Aclarion, Inc. — Investor Relations & Filings

Ticker · ACON ISIN · US6551871022 LEI · 529900MGK6H51761Z546 US Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Filings indexed 247 across all filing types
Latest filing 2026-04-22 Regulatory Filings
Country US United States of America
Listing US ACON

About Aclarion, Inc.

https://aclarion.com/

Aclarion, Inc. is a healthcare technology company that has developed NOCISCAN, a Software-as-a-Service (SaaS) platform for diagnosing chronic low back and neck pain. The company's technology utilizes Magnetic Resonance Spectroscopy (MRS) and proprietary biomarkers to noninvasively analyze intervertebral discs. NOCISCAN complements standard MRI scans, which provide structural information, by delivering objective data on pain biomarkers. This process helps physicians distinguish between painful and non-painful discs. The platform generates individualized NOCI+ (painful) and NOCI- (non-painful) scores for each disc, providing insights intended to help clinicians personalize treatment strategies and optimize surgical plans. The technology aims to serve as an evidence-based tool to pinpoint the source of discogenic pain without requiring invasive diagnostic procedures like provocative discography.

Recent filings

Filing Released Lang Actions
8-K - Aclarion, Inc. (0001635077) (Filer)
Regulatory Filings
2026-04-22 English
SCHEDULE 13G - Aclarion, Inc. (0001635077) (Subject)
Major Shareholding Notification
2026-03-26 English
CURRENT REPORT
Regulatory Filings
2026-01-13 English
CURRENT REPORT
Regulatory Filings
2026-01-09 English
PROSPECTUS SUPPLEMENT TO PROSPECTUS DATED 5-5-25
Prospectus
2026-01-09 English
Director's Dealing 2025
Director's Dealing
2025-12-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.